🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 17 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/04/1999 | 31,35 | 32,75 | 31,35 | 32,75 | +3,32% | 4,48% | 30.217 |
| 19/04/1999 | 32,28 | 32,63 | 31,00 | 31,70 | +0,37% | 5,07% | 55.304 |
| 16/04/1999 | 31,46 | 32,75 | 30,88 | 31,58 | -2,17% | 5,95% | 191.986 |
| 15/04/1999 | 33,69 | 34,86 | 32,28 | 32,28 | -3,50% | 7,64% | 50.628 |
| 14/04/1999 | 33,22 | 34,62 | 32,05 | 33,45 | +2,88% | 7,75% | 58.376 |
| 13/04/1999 | 32,75 | 33,69 | 31,35 | 32,52 | +4,12% | 7,14% | 79.215 |
| 12/04/1999 | 31,00 | 31,35 | 30,65 | 31,23 | -1,84% | 2,26% | 49.212 |
| 09/04/1999 | 32,05 | 32,28 | 31,35 | 31,82 | -0,37% | 2,92% | 50.254 |
| 08/04/1999 | 33,22 | 33,69 | 31,23 | 31,93 | -2,50% | 7,39% | 40.209 |
| 07/04/1999 | 34,15 | 34,39 | 32,28 | 32,75 | -2,78% | 6,16% | 29.468 |
| 06/04/1999 | 33,22 | 33,69 | 31,82 | 33,69 | +0,70% | 5,63% | 53.513 |
| 05/04/1999 | 32,28 | 33,69 | 32,05 | 33,45 | +5,15% | 5,07% | 46.033 |
| 01/04/1999 | 31,11 | 32,75 | 31,11 | 31,82 | +3,82% | 5,26% | 75.608 |
| 31/03/1999 | 32,05 | 33,22 | 30,65 | 30,65 | -3,68% | 8,03% | 107.615 |
| 30/03/1999 | 33,69 | 33,92 | 31,82 | 31,82 | -6,85% | 6,25% | 28.266 |
| 29/03/1999 | 33,22 | 34,15 | 32,75 | 34,15 | +1,39% | 4,23% | 33.236 |
| 26/03/1999 | 32,99 | 34,62 | 32,75 | 33,69 | -0,69% | 5,67% | 34.438 |
| 25/03/1999 | 33,69 | 35,32 | 32,99 | 33,92 | -0,68% | 6,94% | 30.003 |
| 24/03/1999 | 33,22 | 35,09 | 32,75 | 34,15 | +4,29% | 7,04% | 29.362 |
| 23/03/1999 | 33,69 | 35,32 | 32,28 | 32,75 | -6,67% | 9,03% | 29.068 |
| 22/03/1999 | 34,15 | 35,09 | 31,82 | 35,09 | +6,01% | 9,59% | 53.540 |
| 19/03/1999 | 33,92 | 34,86 | 32,99 | 33,10 | -3,08% | 5,52% | 37.644 |
| 18/03/1999 | 34,15 | 34,62 | 33,92 | 34,15 | -1,35% | 2,05% | 35.774 |
| 17/03/1999 | 33,92 | 34,62 | 33,45 | 34,62 | +2,78% | 3,45% | 89.661 |
| 16/03/1999 | 33,22 | 33,92 | 33,22 | 33,69 | +0,00% | 2,11% | 90.302 |
| 15/03/1999 | 32,28 | 34,15 | 31,58 | 33,69 | +5,88% | 7,97% | 71.414 |
| 12/03/1999 | 34,62 | 36,26 | 31,82 | 31,82 | -6,85% | 12,84% | 101.844 |
| 11/03/1999 | 32,75 | 34,15 | 32,28 | 34,15 | +3,55% | 5,71% | 37.991 |
| 10/03/1999 | 33,92 | 34,15 | 32,05 | 32,99 | -0,70% | 6,21% | 42.827 |
| 09/03/1999 | 32,99 | 34,15 | 32,75 | 33,22 | -0,70% | 4,26% | 54.716 |